Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the current study is to establish the bioequivalence of linagliptin/
pioglitazone fixed dose combination tablet compared to single tablets of linagliptin and
pioglitazone administered together.